Establishment Labs Stock (NASDAQ:ESTA)
Previous Close
$38.94
52W Range
$24.01 - $60.12
50D Avg
$43.54
200D Avg
$46.26
Market Cap
$1.15B
Avg Vol (3M)
$509.04K
Beta
1.21
Div Yield
-
ESTA Company Profile
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
ESTA Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| EMEA | $80.15M | - | - |
| Asia Pacific | $33.95M | - | - |
| Latin America | $48.89M | $52.44M | $38.23M |
| Other Geographical Areas | $2.16M | $994.00K | $865.00K |
| Asia Pacific And Middle East | - | $59.56M | $35.68M |
| Europe | - | $48.70M | $51.91M |
Fiscal year ends in Dec 23 | Currency in USD